Clarithromycin Modulates Neutrophilic Inflammation Induced by Prevotella intermedia in Human Airway Epithelial Cells
<b>Objectives:</b> In the present study, we aimed to clarify the mechanisms by which periodontal pathogens, particularly <i>Prevotella intermedia</i>, induce severe neutrophilic inflammation. In addition, we aimed to test the efficacy of macrolides, which has not been resolved in the neutrophilic inflammation induced by <i>P. intermedia</i>. <b>Methods:</b> NCl-H292 human airway epithelial cells were pre-incubated with clarithromycin for 2 h before incubation with <i>P. intermedia</i> supernatants. Then, C-X-C motif chemokine ligand 8 (<i>CXCL8</i>) transcription and interleukin (IL)-8 production were measured. To elucidate the signaling pathway, mitogen-activated protein kinase inhibitors were added to the cell culture, and the cells were subjected to Western blotting. <b>Results:</b><i>P. intermedia</i> supernatants promoted <i>CXCL8</i> transcription and IL-8 production, and the reactions were significantly suppressed by clarithromycin pretreatment. Only trametinib, the selective mitogen-activated extracellular signal-regulated kinase inhibitor, downregulated <i>CXCL8</i> transcription and IL-8 production. Furthermore, Western blotting revealed that stimulation with <i>P. intermedia</i> supernatants specifically induces extracellular signal-regulated kinases (ERK) 1/2 phosphorylation, which is suppressed by clarithromycin pretreatment. Notably, the interference analysis revealed that ERK3 might be dispensable for IL-8 production under the stimulation of <i>P. intermedia</i> supernatants. <b>Conclusions:</b> Our results provide new insight into the mechanism underlying <i>P. intermedia</i>-induced production of IL-8 from human airway epithelial cells. Furthermore, macrolides might have therapeutic potential in regulating periodontal pathogen-induced neutrophilic inflammation in the lungs.
Authors
- Katsunori Yanagihara (ORCID: https://orcid.org/0000-0003-3677-2486)
- Yuya Ito (ORCID: https://orcid.org/0000-0003-1295-4357)
- Masato Tashiro (ORCID: https://orcid.org/0000-0001-7609-7679)
- Takahiro Takazono (ORCID: https://orcid.org/0000-0002-0696-5386)
- Tatsuro Hirayama (ORCID: https://orcid.org/0000-0001-8554-3482)
- Noriho Sakamoto (ORCID: https://orcid.org/0000-0002-7577-476X)
- Ayaka Ota
- Shotaro Ide (ORCID: https://orcid.org/0000-0001-7872-8147)
- Kazuhiro Yatera (ORCID: https://orcid.org/0000-0002-2955-4432)
- Mariko Naito (ORCID: https://orcid.org/0000-0003-0769-7747)
- Koichi Izumikawa (ORCID: https://orcid.org/0000-0001-9969-824X)
- Hiroshi Mukae (ORCID: https://orcid.org/0000-0002-1429-5706)
- Naoki Iwanaga (ORCID: https://orcid.org/0000-0002-0680-390X)
- Naoki Hosogaya (ORCID: https://orcid.org/0000-0002-3229-2277)
- Kosuke Kosai
- Yoshimasa Tanaka (ORCID: https://orcid.org/0000-0002-5024-0614)
- Masataka Yoshida (ORCID: https://orcid.org/0000-0002-5621-955X)
- Kazuaki Takeda (ORCID: https://orcid.org/0000-0003-1611-4435)
- Hiroki Ashizawa
Institutions
- National Institutes of Health (US)
- University of Occupational and Environmental Health Japan (JP)
- National Institute of Allergy and Infectious Diseases (US)
- Nagasaki University Hospital (JP)
- Nagasaki University (JP)
Publication Details
- Journal
- Antibiotics
- Published
- 2024-09-23
- DOI
- https://doi.org/10.3390/antibiotics13090909
- Citations
- 3
- Primary Topic
- Oral microbiology and periodontitis research
- Type
- article
- Field-Weighted Citation Impact
- 1.20
Funders
- Japan Society for the Promotion of Science